Yes it's Akrihin. Bioreaktor will not produce dbol untill they get a new licence. They have problems with it in present. The reason why Akrihin has raised up the prices for its dbol.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.